For Preventive Health
For Healthcare
For Research20
Years of fundamental R&D in eye-movement neuroscience and cognition
Founded on 20 years of neuroscience
Built to bring brain health measurement to clinical practice.
ViewMind is a neuroscience company that measures brain function through the eyes
Founded on 20 years of research linking oculomotor behavior to cognitive and neural processes, the company has produced over 80 peer-reviewed publications and built institutional collaborations spanning three continents.
ViewMind operates two products built on the same core technology:
- ViewMind Neuroscan: designed for preventive health clinics.
- ViewMind Atlas: a clinical and research-grade tool used in institutional settings and large-scale studies.
The company is headquartered in the United States with operations across Latin America, Europe, and Southeast Asia.
Built on 20 years of published neuroscience
Leadership
Mark Edwards
CEO & Co-founder Serial entrepreneur with 30 years as CEO and Chairman. Multiple exits. Background includes Symbian, Microsoft, and Mformation. Drives investor narrative, fundraising, commercialization and strategic partnerships.
Gerardo Fernandez PhD
Scientific researcher with 20+ years of experience researching eye movement patterns, neuroscience, and artificial intelligence.
Matías Shulz
CPO & Co-founder Product and operations leadership. Background: Wuabi, Entravision. Manages the product roadmap, support architecture, and deployment infrastructure.
Romina Carranza
VP Quality & Regulatory Biomedical engineer. QA and Regulatory Affairs management for medical software. Global compliance lead. Manages FDA clearance pathway, quality management systems, and communication guidelines. Previously at Axxion.
Lucía García Giacosa
VP Operations Biomedical engineer. Leads operations, marketing, and client success. Coordinates across product, R&D, commercial, regulatory, and clinical operations. Designs operational structures and manages the connective tissue between strategy and execution.
Ariel Arelovich, PhD
CTO Full-stack software development and eye-tracking systems specialist. Leads the technical architecture of the ViewMind platform.
Board Directors
Mark Edwards
Chairman, CEO & Co-founder
Scarlett Chen
Verge HealthTech Fund
Nicolás Tognalli
CITES
Daniel D'Agostino
Audit Chair
Gerardo Fernandez, PhD
CSO & Co-founder
Backed by
Research and clinical collaborations
Quality Management System
ViewMind maintains an ISO 13485-certified quality management system across its entities.
Data Privacy and Protection
Applicable data privacy and protection requirements, including HIPAA and GDPR considerations, are assessed as part of ViewMind's internal processes and product implementation activities.
Regulatory Status
ViewMind NeuroScan™ falls under an FDA 510(k)-exempt pathway in the United States.
ViewMind Atlas™ is registered in selected LATAM markets, and ViewMind is pursuing FDA clearance for the United States market.